Diabetes Driving Earlier Cataracts in India, Doctors Warn

IMT News Desk
IMT News Desk
· 2 min read
Diabetes linked to rising early-onset cataracts in India; doctors urge regular eye checks and better sugar control to prevent vision loss.

Doctors across India report a worrying increase in cataracts among people in their 40s and 50s, with diabetes emerging as a key driver of earlier onset and faster progression. Ophthalmologists say persistently high blood sugar accelerates clouding of the eye’s natural lens, producing symptomatic vision loss at younger ages.

India now has more than 101 million adults with diabetes and 136 million with prediabetes, according to the International Diabetes Federation figures, which experts say will push cataract cases higher in the coming years. While diabetic retinopathy remains a well-known complication, clinicians note that cataract is becoming an increasingly significant threat, especially in patients with long-standing or poorly controlled diabetes.

“Diabetes is increasingly being recognised as a major contributor to early cataract development,” said Dr Jay Mathew Perumal, Head- Clinical Services, Dr Agarwals Eye Hospital, Trivandrum. “We are seeing more patients in their 40s and 50s presenting with cataracts, particularly those with poorly controlled blood sugar. These lens changes can develop gradually but significantly affect vision during a person’s most active and productive years. Regular eye examinations help identify early lens changes and allow timely treatment before vision loss becomes more severe.”

Doctors say the impact is amplified for working-age adults whose screen-heavy routines, computers, smartphones, video calls and driving make visual disturbances harder to ignore. Typical symptoms include blurred vision, glare, reduced contrast sensitivity, difficulty reading digital screens and frequent changes in spectacle prescription.

Clinicians also caution that persistent misconceptions delay care. “Many patients still believe surgery should only be performed once a cataract has ‘matured,’ or assume vision loss is simply part of ageing,” Dr Perumal said. “Some expect eye drops to reverse the condition, which is not accurate. Delays can lead to advanced cataracts that are more difficult to manage surgically and may affect recovery.”

Ophthalmologists recommend comprehensive eye checks for everyone over 40, and especially for people with diabetes, obesity or hypertension. Early detection allows timely intervention, preserves vision and reduces long-term impact on quality of life. Cataract surgery is now a safe, highly effective procedure, and technological advances including laser and robotic-assisted techniques can improve outcomes when performed promptly.

Dr Agarwals Eye Hospital has announced free cataract evaluations for the public through 15 July 2026 to raise awareness; registrations are available at 95943 69666.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk